| Mr Steven Patrick Keelty, PT | |
|
6873 E Canal Rd, Lockport, NY 14094-9576 | |
| (716) 625-9468 | |
| (716) 625-9468 |
| Full Name | Mr Steven Patrick Keelty |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 6873 E Canal Rd, Lockport, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467641233 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 016365-1 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Steven Patrick Keelty, PT 6873 E Canal Rd, Lockport, NY 14094-9576 Ph: (716) 625-9468 | Mr Steven Patrick Keelty, PT 6873 E Canal Rd, Lockport, NY 14094-9576 Ph: (716) 625-9468 |
News Archive
These advances have been reported in a new scientific article published in the international journal Nature, fruit of the collaboration between Northwestern University (Chicago), Weill Cornell Medical College (New York) and the Institute of Biomedicine of Seville HUVR/CSIC/US/ and Ciberned.
Frailty is the medical term for becoming weaker or experiencing lower levels of activity or energy. Becoming frail as we age increases our risk for poor health, falls, disability, and other serious concerns.
Anapol Schwartz attorneys Lawrence Cohan and Melissa Fry Hague recently filed two Gardasil vaccine complaints – one on behalf of a Kensington, Calif., family, whose 15-year old daughter died after suffering from severe adverse reactions, and another on behalf of a 19-year old Lapeer, Mich., woman, who has a chronic, autoimmune disorder. The cases, filed in The Court of Federal Claims in Washington, D.C., seek recovery under the National Vaccine Injury Compensation Program.
Clementia Pharmaceuticals, Inc. announced today that the European Medicines Agency (EMA) has granted Orphan Medicinal Product Designation for palovarotene, the company's lead product candidate, for the treatment of fibrodysplasia ossificans progressiva (FOP).
OSI Pharmaceuticals, Inc., Genentech, Inc., and Roche today announced that a Phase III study of Tarceva™ (erlotinib HCl), an investigational HER1/EGFR-inhibitor agent in previously treated patients with non-small cell lung cancer (NSCLC), met its primary endpoint of improving overall survival, with patients receiving Tarceva™ living longer than those in the placebo arm of the study.
› Verified 5 days ago
Mr. Neil Arthur Saari, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 5556 Davison Rd, Lockport, NY 14094 Phone: 716-433-3368 | |
Perilli Physical Therapy Pc Physical Therapist Medicare: Medicare Enrolled Practice Location: 5556 Davison Rd, Lockport, NY 14094 Phone: 716-433-3368 Fax: 716-433-2086 | |
Dr. Alana Szewczyk, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 5556 Davison Rd, Lockport, NY 14094 Phone: 716-433-3368 | |
Mrs. Gail Marie Marinaccio, P.T., M.S. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 502 Applewood Dr, Lockport, NY 14094 Phone: 716-434-7499 | |
Body Mechanix Physical Therapy Pllc Physical Therapist Medicare: Medicare Enrolled Practice Location: 5848 Snyder Dr, Lockport, NY 14094 Phone: 716-433-0070 Fax: 716-433-1171 | |
Dr. Mark Jospeh Siedlecki, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 5848 Snyder Dr, Lockport, NY 14094 Phone: 716-433-0070 | |
Mr. Kevin D Klein, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 5848 Snyder Dr, Lockport, NY 14094 Phone: 716-433-0070 Fax: 716-433-1171 |